Eliisa Löyttyniemi

Biostatistic, Biostatistics (Department of Clinical Medicine)

eliisa.loyttyniemi@utu.fi

+358 29 450 4450

+358 50 308 2458

Kiinamyllynkatu 10

Turku

Areas of expertise

Teaching and consulting biostatistics, and analysing all kind of datasets

Research

Biostatistics especially in clinical trials

Publications

10 of 11

Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project (2014)
- European Psychiatry
Salokangas RKR, Heinimaa M, From T, Löyttyniemi E, Ilonen T, Luutonen S, Hietala J, Svirskis T, von Reventlow HG, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Ruhrman S, Klosterkötter J; the EPOS group
(A1 Journal article – refereed)
Trends of weekly musculoskeletal pain from 2000 to 2012: National study of Finnish university students. (2014)
- European Journal of Pain
Oksanen AM, Laimi K, Löyttyniemi E, Kunttu K.
(A1 Journal article – refereed)
Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma (2014)
- Translational Oncology
Silén J, Högel H, Kivinen K, Silvoniemi A, Forsback S, Löyttyniemi E, Solin O, Grénman R, Minn H, Jaakkola PM, Grönroos TJ
(A1 Journal article – refereed)
Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women (2013)
- Osteoporosis International
T Pekkarinen, E Löyttyniemi, M Välimäki
(A1 Journal article – refereed)
Intermittent megadose treatment with vitamin D3 is not optimal to keep serum 25OHD levels at or over the target of 75 nmol/L (2013)
- Osteoporosis International
Valimaki VV, Pekkarinen T, Loyttyniemi E, Valimaki M
(A1 Journal article – refereed)
The effectiveness of teriparatide in the clinical practice-attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment (2013)
- Annals of Medicine
Koski AM, Loyttyniemi E, Vaananen H, Laine H, Niskanen L, Nevalainen PI, Korpi-Hyovalti E, Valimaki MJ
(A1 Journal article – refereed)
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients (2012)
- APMIS
Pelttari H, Schalin-Jantti C, Arola J, Loyttyniemi E, Knuutila S, Valimaki MJ
(A1 Journal article – refereed)
Prevention of hip fractures with an educational program in elderly finnish women: a population-based randomized clinical trial (2012)
- Osteoporosis International
Pekkarinen TA, Loyttyniemi E, Valimaki MJ
(O2 Other)
First Trimester Folate Metabolism and Congenital Heart Defect (2011)
- Reproductive Sciences
Bahado-Singh RO, Akolekar R, Loyttyniemi E, Nicolaides KH
(A1 Journal article – refereed)
LONG-TERM EFFICACY AND TOLERABILITY OF ONCE-YEARLY HISTRELIN ACETATE IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER (2010)
- European Urology Supplements
Shore ND, Gittelman M, Cookson MS, Harnett MD, Loyttyniemi E, Vuorela A, Schlegel PN
(A1 Journal article – refereed)
Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study (2010)
- European Journal of Endocrinology
Pelttari H, Valimaki MJ, Loyttyniemi E, Schalin-Jantti C
(A1 Journal article – refereed)
Serum 25(OH)D-3 vitamin status of elderly Finnish women is suboptimal even after summer sunshine but is not associated with bone density or turnover (2010)
- European Journal of Endocrinology
Pekkarinen T, Turpeinen U, Hamalainen E, Loyttyniemi E, Alfthan H, Valimaki MJ
(A1 Journal article – refereed)
The same annual dose of 292000 IU of vitamin D-3 (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D-3 concentrations and renal function (2010)
- Clinical Endocrinology
Pekkarinen T, Valimaki VV, Aarum S, Turpeinen U, Hamalainen E, Loyttyniemi E, Valimaki MJ
(A1 Journal article – refereed)
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily (2009)
- European Journal of Clinical Pharmacology
Kuoppamaki M, Korpela K, Marttila R, Kaasinen V, Hartikainen P, Lyytinen J, Kaakkola S, Hanninen J, Loyttyniemi E, Kailajarvi M, Ruokoniemi P, Ellmen J
(A1 Journal article – refereed)
Targeted nalmefene with simple medical management in the treatment of heavy drinkers: A randomized double-blind placebo-controlled multicenter study (2007)
- Alcoholism: Clinical and Experimental Research
Karhuvaara S, Simojoki K, Virta A, Rosberg M, Loyttyniemi E, Nurminen T, Kallio A, Makela R
(A1 Journal article – refereed)
The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men (2007)
- BONE
Saarinen A, Valimaki VV, Valimaki MJ, Loyttyniemi E, Auro K, Uusen P, Kuris M, Lehesjoki AE, Makitie O
(A1 Journal article – refereed)
Vitamin D fortification of milk products does not resolve hypovitaminosis D in young Finnish men (2007)
- European Journal of Clinical Nutrition
Valimaki VV, Loyttyniemi E, Valimaki MJ
(A1 Journal article – refereed)
Quality of life in treated patients with acromegaly (2006)
- Journal of Clinical Endocrinology and Metabolism
Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH
(A1 Journal article – refereed)
Quantitative ultrasound variables of the heel in Finnish men aged 18-20 yr: predictors, relationship to bone mineral content, and changes during military service (2006)
- Osteoporosis International
Valimaki VV, Loyttyniemi E, Valimaki MJ
(A1 Journal article – refereed)
A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients (2001)
- Journal of Internal Medicine
Kauppinen-Makelin R, Tahtela R, Loyttyniemi E, Karkkainen J, Valimaki MJ
(A1 Journal article – refereed)